Quarterly Report • Nov 10, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
CONFERENCE CALL PRESENTATION

NOVEMBER 10, 2022









| Strong sales increase y-o-y in all regions mainly driven by disproportionately high Trading Review growth in the Americas and APAC region |
|---|
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Inflation Mitigation | Price increases and efficiency step-ups prove effective in compensating for input cost |
|---|---|
| inflation |
| Aftermarket Strength Group sales |
In spite of strong OE growth, the AM managed to keep pace featuring a 27.7% share in |
|---|---|
| ------------------------------------- | -------------------------------------------------------------------------------------- |
| Pending Haldex | Expected imminent completion. On track to create a stronger, more resilient business |
|---|---|
| Merger | model, enhanced customer offering and enhanced earnings profile |
| Guidance | Group sales now expected to come in around the upper end of the range of EUR 1.4 to 1.5 billion. Adjusted EBIT margin projection unchanged between 7.0% to 8.0% |
|---|---|
| ---------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------- |




* Pre-acquisition / pre-acquisition of HLDX shares


YTD

Sales by Quarter
(in EUR million)
Sales development (by region, by customer category)


2021 2022
Gross Profit by Quarter (in EUR mn and % of sales)



2021 2022

YTD

Sales (in EUR mn)





2021 2022




Sales by Quarter
(in EUR mn)



2021 2022








Adj. EBIT by Quarter (in EUR mn and % of sales)

| in EUR thousands | Q3 2022 | Q3 2021 | Change absolute | Change in % |
|---|---|---|---|---|
| EBIT | 26,957 | 21,396 | 5,561 | 26.0% |
| EBIT margin in % | 6.7% | 6.8% | – | – |
| Additional depreciation and amortisation of property, plant and equipment and intangible assets from PPA |
2,416 | 2,258 | 158 | 7.0% |
| Valuation effects from call and put options | 35 | – | 35 | – |
| Restructuring and transactions costs | 5,271 | 669 | 4,602 | 687.9% |
| Impairment | 1,985 | – | 1,985 | – |
| Adjusted EBIT | 36,664 | 24,323 | 12,341 | 50.7% |
| Adjusted EBIT margin in % | 9.1% | 7.7% | – | – |
• Q3 2022 impairment includes China write-down

| Q1-Q3 | Q1-Q3 | Change | Change | Change | Change | |||
|---|---|---|---|---|---|---|---|---|
| in EUR thousands | 2022 | 2021 | abs. | in % | Q3 2022 | Q3 2021 | abs. | in % |
| Sales | 1,175,641 | 924,762 | 250,879 | 27.1% | 402,388 | 316,638 | 85,750 | 27.1% |
| Cost of sales | –979,212 | -759,384 | -219,828 | 28.9% | -332,703 | -263,281 | -69,422 | 26.4% |
| Gross profit | 196,429 | 165,378 | 31,051 | 18.8% | 69,685 | 53,357 | 16,328 | 30.6% |
| in % of sales | 16.7% | 17.9% | 17.3% | 16.9% | ||||
| Gross profit adjusted | 199,916 | 167,563 | 32,353 | 19,3% | 71,906 | 54,337 | 17,569 | 32.3% |
| in % of sales | 17.0% | 18.1% | 17.9% | 17.2% | ||||
| SG&A | -121,950 | -103,722 | -18,228 | 17.6% | -43,149 | -32,384 | -10,765 | 33.2% |
| in % of sales | -10.4% | -11.2% | -10.7% | -10.2% | ||||
| Operating profit | 74,479 | 61,656 | 12,823 | 20.8% | 26,536 | 20,973 | 5,563 | 26.5% |
| Share of net profit of | ||||||||
| investments accounted | ||||||||
| for using the equity | 1,197 | 1,002 | 195 | 19.5% | 421 | 423 | -2 | -0.5% |
| method | ||||||||
| EBIT | 75,676 | 62,658 | 13,018 | 20.8% | 26,957 | 21,396 | 5,561 | 26.0% |
| in % of sales | 6.4% | 6.8% | 6.7% | 6.8% | ||||
| EBIT adjusted | 92,281 | 71,276 | 21,005 | 29.5% | 36,664 | 24,323 | 12,341 | 50.7% |
| in % of sales | 7.8% | 7.7% | 9.1% | 7.7% | ||||
| Finance result | -6,510 | -6,597 | 87 | -1.3% | -3,167 | -2,174 | -993 | 45.7% |
| Result before taxes | 69,166 | 56,061 | 13,105 | 23.4% | 23,790 | 19,222 | 4,568 | 23.8% |
| Income taxes | -21,427 | -18,950 | -2,477 | 13.1% | -7,322 | -4,659 | -2,663 | 57.2% |
| Tax rate (%) | 31.0% | 33.8% | 30.8% | 24.2% | ||||
| Result for the period | 47,739 | 37,111 | 10,628 | 28.6% | 16,468 | 14,563 | 1,905 | 13.1% |
| in % of sales | 4.1% | 4.0% | 4.1% | 4.6% |


| EUR MN |
12/31/ 2020 |
03/31/ 2021 |
06/30/ 2021 |
09/30/ 2021 |
12/31/ 2021 |
03/31/ 2022 |
06/30/ 2022 |
09/30/ 2022 |
|---|---|---|---|---|---|---|---|---|
| Equity | 300.5 | 325.2 | 334.8 | 353.7 | 371.1 | 390.5 | 431.1 | 468.5 |
| Balance Sheet total |
920.5 | 998.6 | 1,010.4 | 1,022.9 | 1,014.3 | 1,060.4 | 1,156.4 | 1,456.9 |

11,9% 14,4% 14,8% 15,5% 14,8% 15,7% 17,4% 15,9% 12/31/2020 03/31/2021 06/30/2021 09/30/2021 12/31/2021 03/31/2022 06/30/2022 09/30/2022 10% 12% 14% 16% 18% 20%
| EUR MN | 12/31/ 2020 |
03/31/ 2021 |
06/30/ 2021 |
09/30/ 2021 |
12/31/ 2021 |
03/31 2022 |
06/30/ 2022 |
09/30/ 2022 |
|---|---|---|---|---|---|---|---|---|
| Inventories | 126.4 | 155.8 | 176.0 | 195.3 | 194.0 | 211.9 | 237.0 | 237.9 |
| Trade receivables |
95.3 | 130.0 | 148.9 | 147.2 | 136.3 | 176.1 | 184.6 | 187.0 |
| Trade payables |
-107.2 | -147.4 | -163.4 | -160.6 | -145.8 | -179.3 | -176.2 | -187.3 |
| NWC | 114.6 | 138.4 | 161.5 | 181.9 | 184.4 | 208.7 | 245.5 | 237.6 |
| Sales (LTM) | 959.5 | 961.7 | 1,091.4 | 1,175.6 | 1,246.6 | 1,330.7 | 1,411.7 | 1,497.5 |
Net working capital (in % of sales)





Net free cash flow from operating activities* (EUR million)
Net cash flow from operating activities (EUR million)


2021


* Unadjusted EBITDA (LTM)
Haldex Financials Q3 2022

| Sales | Strong sales increase y-o-y. |
|---|---|
| Adj. EBIT margin | Further sequential improvement of EBIT margin in Q3 to 9.9%. |
| SAF-HOLLAND cash offer | After the extended acceptance period which expired on 31 August 2022, SAF-HOLLAND controlled in total 46,746,597 Haldex shares, corresponding to approx. 96.14% of the total number of outstanding shares. |
| Delisting | The last trading day of the Haldex share was 19 September 2022. |
| Squeeze out | SAF HOLLAND has initiated compulsory acquisition proceedings under the Swedish Companies Act to acquire all shares in Haldex not already owned by SAF HOLLAND. |
| Polish merger control clearance |
Merger control clearance from the Polish competition authority is currently still outstanding. The Polish authority has not expressed concerns that the takeover would significantly restrict competition. It has stated though that the case is complex as the relevant markets are interrelated and the parties to the transaction have different roles in these markets. The Polish authority intends to better understand these relationships prior to their clearance decision. As no competition issues have been identified so far (neither by the German nor the US authorities), SAF-HOLLAND is confident that the unconditional clearance will be granted in the next few weeks. |


(in EUR million)

2021 2022


33,7% 14,5% 51,8% Trailer OE Truck OE Aftermarket Q3 2022 33,3% 13,7% 53,0% Trailer OE Truck OE Aftermarket Q3 2021

Sales development (by region, by customer category)
Q3 2022 Call Presentation < 26 >
| P&L in EUR thousands | Q3 2022 | Q3 2021 | Q1-Q3 2022 |
Q1-Q3 2021 |
|---|---|---|---|---|
| Sales | 142.828 | 118.042 | 401.215 | 337.200 |
| Gross profit | 41.193 | 30.915 | 113.894 | 95.007 |
| Gross margin | 28.8% | 26.2% | 28.4% | 28.2% |
| Operating income | 13.268 | 9.402 | 29.968 | 28.274 |
| Operating margin | 9.3% | 8.0% | 7.5% | 8.4% |
| Adj. operating income | 14.232 | 9.833 | 33.192 | 29.286 |
| Adj. operating margin | 9.9% | 8.3% | 8.3% | 8.7% |
| Profit before tax | 12.820 | 7.384 | 26.754 | 24.396 |
| Taxes | -3.587 | -2.016 | -7.484 | -6.691 |
| Net income (incl. minorities) | 9.233 | 5.369 | 19.270 | 17.704 |
| Net Income (excl. minorities) | 9.092 | 5.266 | 18.865 | 17.535 |
| Sales by region in EUR thousands | Q3 2022 | Q3 2021 | Q1-Q3 2022 |
Q1-Q3 2021 |
| Americas | 84.774 | 60.718 | 230.113 | 171.840 |
| EMEA | 49.495 | 49.629 | 145.356 | 140.877 |
| APAC | 8.559 | 7.695 | 25.746 | 24.483 |


| Trailer | Trucks | |
|---|---|---|
| EMEA | -5% | +3% |
| North America | +25% | +17% |
| Brazil | -10% | 0% |
| China | -49% | -49% |
| India | +91% | +53% |
Sources: Market data for trucks and trailers based on ACT Research (September 2022), ANFAVEA (September 2022), ARTSA (September 2022), SIAM (September 2022)

| March 17, 2022 | May 5, 2022 | July 28, 2022 | |
|---|---|---|---|
| Sales | EUR 1.15bn to EUR 1.3bn |
EUR 1.2bn to EUR 1.35bn |
EUR 1.4 bn to EUR 1.5 bn |
| Adjusted EBIT margin |
Significantly below 2021 |
6.5% to 7.0% | 7.0% to 8.0% |
| Capex ratio | 2% to 2.5% | 2% to 2.5% | 2% to 2.5% |

Contact and additional information

| Issuer & contact | Additional information | ||
|---|---|---|---|
| SAF-HOLLAND SE | ISIN | DE000SAFH001 | |
| Hauptstrasse 26 | WKN | SAFH00 | |
| 63856 Bessenbach | Listing | Frankfurt Stock Exchange Prime Standard |
|
| Stephan Haas Tel: +49 6095 301 – 803 |
|||
| Financial calendar 2022 | |||
| Michael Schickling | |||
| Tel: +49 6095 301 – 617 |
November 10, 2022 | Q3 2022 Quarterly Statement | |
| Alexander Pöschl Tel: +49 6095 301 – 117 |
November 15 + 16, 2022 | Roadshow Helsinki and Stockholm | |
| Email: [email protected] | December 8, 2022 | Berenberg European Conference 2022 | |
| January 10, 2022 | Oddo BHF Forum 2023 | ||
| January 17, 2022 | UniCredit /Kepler Cheuvreux German Corporate Conference 2023 |
||
This presentation has been prepared by SAF-HOLLAND SE ("SAF-HOLLAND") and comprises written materials concerning SAF-HOLLAND. It is furnished to you solely for your information and may not be reproduced or redistributed, in whole or in part, to any other person. It contains summary information only and does not purport to be comprehensive and is not intended to be (and should not be used as) the sole basis of any analysis or other evaluation of SAF-HOLLAND or its business. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and, accordingly, neither SAF-HOLLAND nor any of the members of its management board or any of its officers, employees or advisors nor any other person shall have any responsibility or liability whatsoever (for negligence or otherwise) arising, directly or indirectly, from the use of this presentation, or its contents or otherwise in connection with this presentation.
This presentation contains certain statements related to our future business and financial performance and future events or developments involving SAF-HOLLAND and/or the industry in which SAF-HOLLAND operates that may constitute forward-looking statements. These statements may be identified by words such as "believes," "expects," "predicts," "intends," "projects," "plans," "estimates," "aims," "foresees," "anticipates," "targets," and similar expressions. Forward-looking statements are not historical facts, but solely opinions, views and forecasts which are based on current expectations and certain assumptions of SAF-HOLLAND's management or cited from third party sources which are uncertain and subject to risks. Actual events may differ significantly from the anticipated developments due to a number of factors, including without limitation, changes in general economic conditions, changes affecting the fair values of the assets held by SAF-HOLLAND and its subsidiaries, changes affecting interest rate levels, changes in competition levels, changes in laws and regulations, environmental damages, the potential impact of legal proceedings and actions and the Group's ability to achieve operational synergies from past or future acquisitions. Should any of these risks or uncertainties materialise or should underlying expectations not occur or assumptions prove to be incorrect, actual results, performance or achievements of SAF-HOLLAND may (negatively or positively) vary materially from those described, explicitly or implicitly, in the relevant forward-looking statement.
The information contained in this presentation, including any forward-looking statements expressed herein, speaks only as of the date hereof and reflects current legislation and the current business and financial affairs of the SAF-HOLLAND which are subject to change and audit. Neither the delivery of this presentation nor any further discussions of SAF-HOLLAND with any of the recipients thereof shall, under any circumstances, create any implication that there has been no change in the affairs of SAF-HOLLAND since such date. Consequently, SAF-HOLLAND neither accepts any responsibility for the future accuracy of the information contained in this presentation, including any forward-looking statements expressed herein, nor assumes any obligation, to update or revise this information to reflect subsequent events or developments which differ from those anticipated.
* This presentation is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This presentation is for information purposes only and does neither constitute an offer to sell securities, nor any recommendation of, or solicitation of an offer to buy, any securities of SAF-HOLLAND in the United States, Germany or any other jurisdiction. In the United States, any securities may not be offered or sold absent registration or an exemption from registration under the U.S. Securities Act of 1933.
The information contained in this document has not been subject to any independent audit or review. Information derived from unaudited financial information should be read in conjunction with the relevant audited financial statements, including the notes thereto. Certain financial data included in the document consists of "non-IFRS financial measures". These non-IFRS financial measures may not be comparable to similarly titled measures presented by other companies, nor should they be construed as an alternative to other financial measures determined in accordance with IFRS. You are cautioned not to place undue reliance on any non-IFRS financial measures and ratios included herein.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.